We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Little Benefit in Mammography for Older Women with Comorbidities

By HospiMedica International staff writers
Posted on 18 Sep 2019
A new study suggests that women 75 and older who suffer from chronic diseases are unlikely to benefit from mammograms.

Researchers at the University of California, San Francisco (UCSF; USA) and Georgetown University Medical Center (GUMC; Washington DC, USA) conducted a study to evaluate the benefit of screening mammography in older women. More...
The researchers examined 10-year cumulative incidence of breast cancer, ductal carcinoma in situ (DCIS), and death from breast cancer and other causes in 222,088 women with at least one mammogram taken between the ages of 66 and 94. In all, 7,583 women were diagnosed with invasive breast cancer and 1,742 with DCIS.

Over the 10 years, 471 women died from breast cancer and 42,229 died from other causes, a nearly 90-fold difference. Other findings were that women 75-84 years of age were 123 times more likely to die of causes other than breast cancer; estimates were even higher among women age 85 and older. The risk of dying from breast cancer stayed steady as the risk of dying from non-breast cancer causes increased; conversely, the risk of being diagnosed with breast cancer decreased slightly after age 75, regardless of women's overall health status. The study was published on September 6, 2019, in the Journal of the National Cancer Institute.

“Cumulative incidence of other cause death was many times higher than breast cancer incidence and death, depending on comorbidity and age. Hence, older women with increased comorbidity may experience diminished benefit from continued screening,” said senior author Dejana Braithwaite, PhD, of GUMC. “Our findings shed light on what age may be the best stopping point for mammography. If you have chronic illnesses after age 75, our findings do not support continuing mammograms.”

The debate over the need for screening mammography in middle aged women has raged since 2009, when the U.S. Preventive Services Task Force (USPSTF, Rockville, MD, USA) recommended that routine mammography for women aged 40-49 should not be performed, as cancer risk is low, while the risk of false–positive results and over-diagnosis and overtreatment is high. In fact, the issue of over-diagnosis is a growing problem in all Western countries, where national screening programs are prevalent.

Related Links:
University of California, San Francisco
Georgetown University Medical Center


Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Heavy-Duty Wheelchair Scale
6495 Stationary
Gold Member
Electrode Solution and Skin Prep
Signaspray
OR Table Accessory
Angular Accessory Rail
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.